Announcements Trials

Browse Landscape

Phase

Phase 1 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 24 Neoplasm Metastasis 8 Leukemia, Myeloid, Acute 8 Carcinoma, Renal Cell 7 Ovarian Neoplasms 6 Lymphoma, Non-Hodgkin 6 Carcinoma, Non-Small-Cell Lung 6 Stomach Neoplasms 5 Colorectal Neoplasms 5 Breast Neoplasms 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Neuroblastoma 4 Neoplasms 4 Lymphoma 4 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Esophageal Neoplasms 3 Colonic Neoplasms 3 Uveal Melanoma 2 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Multiple Myeloma 2 Mesothelioma, Malignant 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2

Interventions

pembrolizumab 3 toripalimab 1 spartalizumab 1 sotorasib 1 pazopanib 1 palbociclib 1 abemaciclib 1 Trastuzumab 1 Therapeutics 1 Jupiter 1 Interleukin-2 1 Immune Checkpoint Inhibitors 1 Fulvestrant 1 EBI-005 1 Cetuximab 1 Catalytic Domain 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Solid Tumor, Adult × Interleukin-2 × Clear all

NCT05307874 2025-12-24

EVICTION-2

ImCheck Therapeutics

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡